Press Release: Innocan Pharma Reports Third Quarter 2024 Financial Results

Dow JonesNov 21 05:01

Innocan Pharma Submits Investigational New Animal Drug Application to FDA's Veterinary Center

MT NewswiresJul 27 04:13

Innocan Pharma Engages Pain-Management Expert Ahead of FDA Meeting

MT NewswiresJul 3 04:21

Innocan Pharma Announces Successful Preliminary Safety Evaluation of LPT-CBD in Minipigs

MT NewswiresJun 12 04:30

CBD-Focused Innocan Pharma Achieves 4X Revenue Growth In Q1, Hits $6.8M Mark

BenzingaMay 28 22:57

InnoCan Pharma Brief: FDA Has Granted Innocan Pharma a Meeting Date for LPT-CBD for Chronic Pain

MT NewswiresMay 22 04:02